Osisko Development Announces Further Upsize of Previously Announced "Bought Deal" Offering

Executive Summary

• Osisko Development Corp. amended its previously announced bought‑deal financing, increasing the total offering size from C$60 million to C$75 million.
• The amendment adds approximately C$15 million to the concurrent private placement, now comprising 5,230,200 common shares at C$4.78 per share for gross proceeds of about C$25.0 million.
• Closing of both the LIFE offering and the concurrent private placement is expected on or about October 29 2025, subject to regulatory approvals.

Key Details

• Amendment Scope: Increase of total financing from C$60 M to C$75 M.
• LIFE Offering (Flow‑Through Shares): Remains at gross proceeds of approximately C$50 M; structure unchanged (three tranches under NI 45‑106 “listed issuer financing exemption”).
• Concurrent Private Placement:
• Size increased by ~C$15 M.
• Total shares offered: 5,230,200 common shares.
• Price per share: C$4.78.
• Gross proceeds after amendment: C$25,000,356.
• Closing Date: Expected on or about October 29 2025 for both the LIFE offering and the concurrent private placement.
• Regulatory Conditions: Closing subject to receipt of all required approvals, including conditional approval from the TSX Venture Exchange and the New York Stock Exchange.
• Statutory Hold Period: Shares issued in the concurrent private placement will be subject to a four‑month‑plus‑one‑day hold period under Canadian securities law.
• Underwriters/Co‑Bookrunners: National Bank Financial Inc., BMO Capital Markets, and RBC Capital Markets.

Notable Quotes

(No CEO or executive quotes were included in the release.)